NO20082757L - Substituerte imidazoquinoliner, imidazonaftyridiner og imidazopyridiner, sammensetninger og fremgangsmater - Google Patents

Substituerte imidazoquinoliner, imidazonaftyridiner og imidazopyridiner, sammensetninger og fremgangsmater

Info

Publication number
NO20082757L
NO20082757L NO20082757A NO20082757A NO20082757L NO 20082757 L NO20082757 L NO 20082757L NO 20082757 A NO20082757 A NO 20082757A NO 20082757 A NO20082757 A NO 20082757A NO 20082757 L NO20082757 L NO 20082757L
Authority
NO
Norway
Prior art keywords
methods
imidazo
imidazonaphthyridines
imidazopyridines
compositions
Prior art date
Application number
NO20082757A
Other languages
English (en)
Norwegian (no)
Inventor
Bryon A Merrill
Chad A Haraldson
Ryan B Prince
Karl J Manske
Tushar Ashok Kshirsagar
Philip Dale Heppner
Luke T Dressel
Larry R Krepski
Michael J Rice
Original Assignee
Coley Pharm Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coley Pharm Group Inc filed Critical Coley Pharm Group Inc
Publication of NO20082757L publication Critical patent/NO20082757L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20082757A 2005-12-16 2008-06-18 Substituerte imidazoquinoliner, imidazonaftyridiner og imidazopyridiner, sammensetninger og fremgangsmater NO20082757L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75139205P 2005-12-16 2005-12-16
PCT/US2006/048017 WO2007075468A1 (fr) 2005-12-16 2006-12-15 Imidazoquinoléines, imidazonaphtyridines et imidazopyridines substituées, compositions et procédés correspondants

Publications (1)

Publication Number Publication Date
NO20082757L true NO20082757L (no) 2008-09-04

Family

ID=38218311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082757A NO20082757L (no) 2005-12-16 2008-06-18 Substituerte imidazoquinoliner, imidazonaftyridiner og imidazopyridiner, sammensetninger og fremgangsmater

Country Status (11)

Country Link
EP (1) EP1968587A1 (fr)
JP (1) JP2009519955A (fr)
KR (1) KR20080077982A (fr)
CN (1) CN101330916A (fr)
AU (2) AU2006332000A1 (fr)
CA (1) CA2634017A1 (fr)
IL (1) IL191846A0 (fr)
MX (1) MX2008007864A (fr)
NO (1) NO20082757L (fr)
WO (1) WO2007075468A1 (fr)
ZA (1) ZA200805105B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06001674A (es) 2003-08-12 2006-05-12 3M Innovative Properties Co Compuestos que contienen imidazo hidroxilamina-sustituidos.
EP1658076B1 (fr) 2003-08-27 2013-03-06 3M Innovative Properties Company Imidazoquinolines substituees par aryloxy et arylalkyleneoxy
EP1660026A4 (fr) 2003-09-05 2008-07-16 3M Innovative Properties Co Traitement pour le lymphome a cellules b cd5+
AU2004278014B2 (en) 2003-10-03 2011-04-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CN1906192A (zh) 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
EP1685129A4 (fr) 2003-11-14 2008-10-22 3M Innovative Properties Co Composes d'un anneau d'imidazo substitues par oxime
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
WO2005066170A1 (fr) 2003-12-29 2005-07-21 3M Innovative Properties Company Imidazoquinolines a substitution arylalcenyle et arylalkynyle
CA2551399A1 (fr) 2003-12-30 2005-07-21 3M Innovative Properties Company Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
WO2005094531A2 (fr) 2004-03-24 2005-10-13 3M Innovative Properties Company Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide
WO2005123080A2 (fr) 2004-06-15 2005-12-29 3M Innovative Properties Company Imidazoquinolines et imidazonaphthyridines substituees par un heterocyclyle contenant un azote
WO2006038923A2 (fr) 2004-06-18 2006-04-13 3M Innovative Properties Company Imidazonaphthyridines substituees par aryle
WO2006009826A1 (fr) 2004-06-18 2006-01-26 3M Innovative Properties Company Thiazoloquinolines et thiazolonaphtyridines substitues par aryloxy et arylalkyleneoxy
WO2006065280A2 (fr) 2004-06-18 2006-06-22 3M Innovative Properties Company Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole
EP1831221B1 (fr) 2004-12-30 2012-08-08 3M Innovative Properties Company Composes chiraux 1,2 imidazo 4,5-c substitues a noyau fusionne
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレイテッド ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2008008432A2 (fr) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
GB0919423D0 (en) * 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
RU2012132278A (ru) 2010-01-12 2014-02-20 Ф. Хоффманн-Ля Рош Аг Трициклические гетероциклические соединения, содержащие их композиции и способы их применения
EP2571877B1 (fr) * 2010-05-17 2018-08-15 Boehringer Ingelheim International GmbH 1h-imidazo[4,5-c]quinoléines
US9062046B2 (en) 2010-07-16 2015-06-23 Piramal Enterprises Limited Substituted imidazoquinoline derivatives as kinase inhibitors
CN103124731B (zh) * 2010-09-16 2016-01-20 和记黄埔医药（上海）有限公司 稠合的杂芳基化合物及其应用
AU2011301518B2 (en) * 2010-09-16 2014-07-03 Hutchison Medipharma Limited Fused heteroaryls and their uses
GB201106799D0 (en) * 2011-04-21 2011-06-01 Glaxosmithkline Llc Novel compounds
GB201114103D0 (en) 2011-08-17 2011-09-28 Glaxosmithkline Llc Novel compounds
US9227969B2 (en) 2013-08-14 2016-01-05 Novartis Ag Compounds and compositions as inhibitors of MEK
EP3992191A1 (fr) 2020-11-03 2022-05-04 Deutsches Krebsforschungszentrum Dérivés d'imidazo[4,5-c]quinoline et leur utilisation en tant qu'inhibiteurs de kinase atm

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003301052A1 (en) * 2002-12-20 2004-07-22 3M Innovative Properties Company Aryl / hetaryl substituted imidazoquinolines
MXPA06001674A (es) * 2003-08-12 2006-05-12 3M Innovative Properties Co Compuestos que contienen imidazo hidroxilamina-sustituidos.
CN1914203A (zh) * 2003-12-04 2007-02-14 3M创新有限公司 砜取代的咪唑环醚
CA2551399A1 (fr) * 2003-12-30 2005-07-21 3M Innovative Properties Company Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle

Also Published As

Publication number Publication date
CA2634017A1 (fr) 2007-07-05
MX2008007864A (es) 2009-03-04
EP1968587A1 (fr) 2008-09-17
ZA200805105B (en) 2009-06-24
KR20080077982A (ko) 2008-08-26
JP2009519955A (ja) 2009-05-21
AU2006332000A1 (en) 2007-07-05
IL191846A0 (en) 2008-12-29
WO2007075468A1 (fr) 2007-07-05
AU2011201519A1 (en) 2011-04-21
CN101330916A (zh) 2008-12-24

Similar Documents

Publication Publication Date Title
NO20082757L (no) Substituerte imidazoquinoliner, imidazonaftyridiner og imidazopyridiner, sammensetninger og fremgangsmater
WO2007106852A3 (fr) Composés à anneaux de [1,2]imidazo[4,5-c] fusionnés substitués, et procédés associé
WO2005094531A3 (fr) Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide
ATE555786T1 (de) 1-alkoxy 1h-imidazo-ringsysteme und verfahren
WO2008008432A3 (fr) Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
WO2006074003A3 (fr) Composes chiraux a cycle [1,2]imidazo[4,5] fusionne
WO2005123079A3 (fr) Imidazopyridines, imidazoquinolines et imidazonaphthyridines a substitution uree
WO2006028545A3 (fr) Imidazoquinolines, imidazopyridines, et imidazonaphthyridines substituees
WO2006107771A3 (fr) Pyrazolo[3,4-c]quinolines, pyrazolo[3,4-c]naphthyridines, analogues de ceux-ci, et procedes
WO2006086633A3 (fr) Composes cycliques [1,2]imidazo[4,5-c] fusionnes substitues et procedes associes
MX2018002017A (es) Compuestos de anillo de imidazo[4,5-c] sustituido con guanidina.
NZ607060A (en) Substituted imidazoquinoline derivatives as kinase inhibitors
DK1539752T3 (da) Fremstilling af 1H-imidazo(4,5-c)quinolin-4-aminer via ny imidazo(4,5-c)quinolin 4-cyano og 1H-imidazo(4,5-c)quinolin-4-carboxamid mellemprodukter
IL220544A (en) History of n - (h1 - indazole - 4 - ram) imidazo [2,1 - a] pyridine - 3 - carboxamide, processes for their preparation and pharmaceutical preparations containing them
WO2006065280A3 (fr) Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole
WO2006086634A3 (fr) Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
RS20080128A (en) Hydroxy substituted 1h-imidazopyridines and methods
WO2006107853A3 (fr) Pyrazolopyridine-1,4-diamines et analogues associes
MX2012007175A (es) Derivados de imidazopiridina como inhibidores de jak.
WO2007143526A3 (fr) Tétrahydroimidazonaphtyridines substituées et procédés
WO2012143416A3 (fr) Nouveaux composés
BRPI1012697A2 (pt) derivados imidazo[1,2-a]piridina substituídos, composições farmacêuticas, e métodos de uso como inibidores da b-secretase
UA99459C2 (en) 9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
MEP23808A (en) Pyridine[3,4-b]pyrazinones
WO2009143156A3 (fr) Composés imidazo[1,2-a]pyridines

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application